# US Surgical Stents Market > US Surgical Stents Market Research Report By Type (Cardiac Stents, Urinary Stents, Biliary Stents, Esophageal Stents, Prostatic Stents, Other), By Type Of Materials (Metal, Standard Polymer, Biodegradable Polymer), By Application (Cardiac Diseases, Urinary Tract Diseases, Other) and By End User (Hospital, Clinics) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 4.83% - **2024:** $ 1,274.7 Million - **2025:** $ 1,336.27 Million - **2035:** $ 2,141.58 Million - **Key Players:** Medtronic (IE), Boston Scientific (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Johnson & Johnson (US), Terumo Corporation (JP), Cook Medical (US), Cardinal Health (US), Stryker Corporation (US) **Report ID:** MRFR/MED/18502-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-surgical-stents-market-20049 --- ## Market Summary ## **US Surgical Stents Market Overview** As per MRFR analysis, the US Surgical Stents Market Size was estimated at 2.83 (USD Billion) in 2023. The US Surgical Stents Market Industry is expected to grow from 3.5(USD Billion) in 2024 to 8.5 (USD Billion) by 2035. The US Surgical Stents Market CAGR (growth rate) is expected to be around 8.401% during the forecast period (2025 - 2035). ### **Key US Surgical Stents Market Trends Highlighted** The US Surgical Stents Market is witnessing several important trends shaping its landscape. One of the key market drivers is the increasing prevalence of chronic diseases, such as cardiovascular and urological conditions, leading to a higher demand for surgical stenting procedures. According to the Centers for Disease Control and Prevention (CDC), heart disease is a leading cause of death in the US, which drives the need for innovative stent technologies that cater to a growing patient population. Moreover, advancements in stent designs, materials, and coatings are being explored, enhancing patient outcomes and expanding their applications in minimally invasive surgeries. Opportunities within the US market are also burgeoning, particularly around the aging population that is more susceptible to health issues requiring stenting. Innovative technologies, such as bioresorbable stents and drug-eluting stents, present significant opportunities for manufacturers to cater to evolving medical needs. The implementation of telehealth and remote monitoring solutions is likely to further augment the market by providing better patient management and follow-up care. Recent trends show a shift towards patient-centric approaches, with an emphasis on personalized medicine and tailored treatment plans based on individual patient profiles. This customization is being propelled by technological advances in medical imaging and data analytics, helping healthcare professionals make better decisions regarding stent applications. Additionally, regulatory bodies are actively involved in ensuring the safety and efficacy of stents, leading to a more structured approval process for new devices, which supports the overall growth of the market in the US. Overall, these trends underscore the dynamic nature of the US Surgical Stents Market, with significant implications for stakeholders involved in the healthcare sector. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Surgical Stents Market Drivers** ### **Increasing Prevalence of Cardiovascular Diseases** The US is witnessing a growing incidence of cardiovascular diseases, which significantly drives the US Surgical Stents Market Industry. According to the American Heart Association, approximately 697,000 deaths were reported in 2020 due to heart disease, making it the leading cause of death in the country. Furthermore, the Centers for Disease Control and Prevention reports that one in every five deaths in the US is attributed to cardiovascular conditions. This increasing prevalence leads to a higher demand for surgical interventions, including the implantation of stents, thereby facilitating market growth. Companies like Boston Scientific and Medtronic are innovating with advanced stent technologies to address this escalating health crisis, which underscores the vital role that surgical stents play in the treatment of heart disease in the United States. ### **Technological Advancements in Stent Design** Innovations in stent technologies are significantly influencing the US [Surgical Stents Market](../../../reports/surgical-stents-market-1044) Industry. The introduction of drug-eluting stents and bioresorbable stents has revolutionized how cardiovascular diseases are treated. According to industry reports, the adoption of drug-eluting stents reduces the risk of restenosis by up to 50% compared to bare-metal stents. Companies such as Abbott and Terumo have invested substantially in Research and Development to refine these technologies. The Food and Drug Administration emphasizes the importance of such advancements, paving the way for more effective and safer treatment options for patients across the United States. ### **Aging Population** The aging population in the US serves as a significant market driver for the US Surgical Stents Market Industry. By 2030, it is projected that one in five US residents will be 65 years old or older, according to the US Census Bureau. This demographic shift causes an increased incidence of diseases such as atherosclerosis, which directly correlates with higher stent utilization rates for cardiovascular interventions. Organizations like the National Institutes of Health report that older adults are more likely to experience vascular complications necessitating surgical procedures. The implications of this aging demographic present expansive growth prospects for companies focused on surgical stents, including major players like Abbott Laboratories and Boston Scientific. ## **US Surgical Stents Market Segment Insights** ### **Surgical Stents Market Type Insights** The US Surgical Stents Market, categorized by Type, showcases a diverse range of stenting solutions that cater to various medical needs. The market encompasses key segments including Cardiac Stents, Urinary Stents, Biliary Stents, Esophageal Stents, Prostatic Stents, and other specialized stents. In the medical field, the application of stents has proven vital in enhancing patient outcomes, particularly in cardiovascular interventions where Cardiac Stents play a crucial role in preventing artery blockages. This segment is pivotal due to the prevalence of coronary artery diseases in the US, driving demand for effective interventions that support patients in maintaining healthier lives. Urinary Stents have similarly gained significant traction, addressing conditions such as urinary obstruction and complications related to kidney stones. These devices are critical in ensuring the unobstructed flow of urine, thus preventing potential kidney damage and other adverse effects associated with obstruction. The necessity for timely and effective management in this area creates opportunities for innovation and improvement within the market. Biliary Stents are also crucial, particularly for patients facing bile duct obstructions often due to malignant conditions. Their role in facilitating bile drainage dramatically impacts treatment plans and patient quality of life, which contributes to their growing importance recognized within the healthcare framework. Meanwhile, the urgency for Esophageal Stents has risen, especially as they address strictures resulting from various conditions, including cancer. These stents enable patients to maintain essential nutritional intake and improve overall quality of life, making them a critical addition to therapeutic measures. Prostatic Stents, though a smaller market segment, cater to male patients suffering from benign prostatic hyperplasia (BPH) and have become increasingly popular due to the rising geriatric population in the US. As the aging demographic grows, the demand for such interventions is anticipated to increase, reflecting the need for effective management strategies in urologic health. Other stents present in the market might encompass various specialties and emerging technologies that are continuously evolving to meet specific patient and procedural demands. With advancements in materials and technology, the US Surgical Stents Market reflects a strong trend toward minimally invasive procedures, which resonate with the increasing patient preference for such options. Growth drivers include a growing geriatric population and advancements in stent technologies that elevate effectiveness and reduce complications. However, market challenges such as regulatory hurdles, varying reimbursement policies, and competition from alternative treatments need to be navigated to leverage opportunities for expansion. This intricate segmentation highlights the multifaceted nature of the US Surgical Stents Market, necessitating a comprehensive understanding to cater to the needs of diverse patient populations effectively. Overall, the demand is poised for substantial growth, underscoring the essential nature of these medical devices in contemporary healthcare. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Surgical Stents Market Type Of Materials Insights** The US Surgical Stents Market is experiencing significant growth, driven by advancements in healthcare technologies and increasing prevalence of chronic diseases. Within the Type of Materials segment, various materials such as metal, standard polymer, and biodegradable polymer are utilized, each playing a vital role. Metal stents are often favored for their strength and durability, providing essential support in critical procedures. Conversely, standard polymer stents offer flexibility and ease of insertion, contributing to patient comfort during treatment. Biodegradable polymer stents are emerging as a transformative option, gradually dissolving within the body and minimizing long-term complications. This material variety not only ensures that healthcare providers can select the most suitable stent for individual patient needs but also enhances the overall effectiveness of surgical interventions. The US clinical guidelines increasingly support the integration of these materials, promoting innovations that align with the growing trend towards personalized medicine. As the US population ages and the incidence of cardiovascular diseases rises, the demand for diverse surgical stents increases, indicating robust market potential for future growth. ### **Surgical Stents Market Application Insights** The Application segment of the US Surgical Stents Market is characterized by its diverse focus on various health conditions requiring stenting, particularly in Cardiac Diseases and Urinary Tract Diseases. Cardiac stenting remains critical due to the rising prevalence of cardiovascular diseases in the US, driven by factors such as an aging population and increased incidences of lifestyle-related conditions. This sector continues to innovate with advanced technologies and materials, enhancing patient outcomes and recovery times. Urinary Tract Diseases also represent a significant portion of the market, where stents are essential for managing obstructions and aiding the healing process after procedures. The importance of urinary stenting is amplified by the growing awareness and diagnosis of kidney-related ailments in the US. Other applications encompass a wide variety of specialty uses, contributing to the overall market growth and providing opportunities for advancements in minimally invasive techniques. The US Surgical Stents Market statistics reflect robust investment and research driving these segments, as healthcare providers seek effective solutions tailored to patient needs across these critical applications. ### **Surgical Stents Market End User Insights** The US Surgical Stents Market is predominantly influenced by its End User segment, which includes Hospital and Clinics, representing critical components in healthcare delivery. Hospitals play a vital role due to their capacity to perform complex surgical procedures and provide advanced care, thereby driving the demand for various types of surgical stents. Clinics, on the other hand, offer a more accessible healthcare option for patients requiring minor procedures and follow-ups, capturing a significant share of the market. Their ability to cater to outpatient services effectively supports the overall utilization of stents. Factors such as the rising prevalence of chronic diseases, including cardiovascular and urological conditions, are contributing to increased surgical interventions across these facilities. Moreover, advancements in medical technology are enhancing the efficiency and effectiveness of stent procedures while leading to improved patient outcomes. The growth in patient awareness regarding minimally invasive surgeries is further bolstering the demand in both Hospitals and Clinics, creating ample opportunities for market players. With a focus on patient-centered care, these settings continue to adapt and expand their surgical capabilities, significantly impacting the US Surgical Stents Market dynamics. ## **US Surgical Stents Market Key Players and Competitive Insights** The US Surgical Stents Market is characterized by a dynamic and competitive environment that reflects the ongoing advancements in medical technology and a growing demand for minimally invasive surgical procedures. With a variety of stents designed for different applications, including vascular, urological, and gastrointestinal uses, the market has attracted numerous key players who strive to innovate and improve patient outcomes. Companies are focusing on enhancing the biocompatibility and functionality of stents, while also addressing the cost-effectiveness and accessibility of these medical devices. The competitive landscape is shaped by various factors such as product development, market strategies, partnerships, and mergers, which contribute to a rapidly evolving marketplace that actively seeks to meet the diverse needs of healthcare providers and patients alike. Halyard Health has established a notable presence in the US Surgical Stents Market, leveraging its expertise in medical devices and commitment to quality and innovation. The company is recognized for its strategic focus on the development of advanced stenting solutions that cater specifically to the surgical needs of healthcare professionals. Halyard Health's strengths lie in its extensive product portfolio, which enhances surgical procedures and provides reliable options across various specialties. The brand's reputation for high standards of manufacturing and robust logistics has enabled it to foster strong relationships with healthcare providers, ensuring that its stents are readily available when needed. In addition, Halyard Health consistently invests in research and development to maintain its competitive edge and respond adeptly to evolving market demands. Teleflex has also made significant strides in the US Surgical Stents Market through its diverse range of medical devices focused primarily on improving patient care and surgical efficiency. The company offers several key products within the stent category, targeting areas such as vascular surgery and urology, which are crucial to the overall health system. Teleflex's market presence is underpinned by its strategic approach to mergers and acquisitions that expand its product reach and enhance its capabilities in stent manufacturing. By integrating innovative technologies and maintaining a portfolio of established brands, Teleflex creates a synergistic effect that not only strengthens its position in the market but also improves the quality and performance of its stenting solutions. The company's ongoing commitment to excellence, combined with its ability to adapt to the changing healthcare landscape, positions it as a formidable player in the US Surgical Stents Market. ### **Key Companies in the US Surgical Stents Market Include** ## **US Surgical Stents Market Industry Developments** Recent developments in the US Surgical Stents Market have shown significant activity, with companies like Boston Scientific and Medtronic launching new devices aimed at improving patient outcomes. Notably, Abbott has been focusing on innovations that cater to the cardiovascular sector, enhancing its presence in the market. In terms of mergers and acquisitions, Halyard Health recently announced strategic collaborations to enhance its product offerings, while Teleflex has made moves to acquire specific technologies that bolster its minimally invasive solutions. Furthermore, in June 2022, Stryker completed its acquisition of Mako Surgical, expanding its capabilities in robotic-assisted surgery, which indirectly impacts the stent market. The US Surgical Stents Market valuation is witnessing growth driven by rising cardiovascular diseases and increased demand for minimally invasive procedures, with organizations advocating for better healthcare measures. Major companies including Johnson and Johnson, AngioDynamics, and Cook Medical are responding to these trends by investing in Research and Development to introduce advanced stent technologies. Market dynamics in the past couple of years, particularly in 2020 and 2021, have intensified competition, as firms strive to maintain leadership amidst evolving healthcare needs and technological advancements. ## **US Surgical Stents Market Segmentation Insights** ### **Surgical Stents Market Type****Outlook** ### **Surgical Stents Market Type Of Materials****Outlook** ### **Surgical Stents Market End User****Outlook** ## Market Drivers ### Technological Innovations in Stent Design Technological innovations in stent design are transforming the surgical stents market. The introduction of bioresorbable stents and advanced drug-eluting technologies has revolutionized treatment options for patients with arterial blockages. These innovations not only improve the efficacy of stenting procedures but also reduce the risk of complications, such as restenosis. The market for drug-eluting stents alone was valued at approximately $3.5 billion in 2023, indicating a strong preference for these advanced solutions among healthcare providers. Furthermore, ongoing research and development efforts are likely to yield even more sophisticated stent designs, enhancing patient outcomes and driving market growth. As healthcare professionals increasingly adopt these innovations, the surgical stents market is expected to expand significantly. ### Increasing Prevalence of Cardiovascular Diseases the rising incidence of cardiovascular diseases in the US is a primary driver of the surgical stents market.. According to the American Heart Association, cardiovascular diseases account for approximately 697,000 deaths annually, highlighting the urgent need for effective treatment options. Surgical stents are increasingly utilized to alleviate blockages in coronary arteries, thereby improving patient outcomes. The demand for stenting procedures is projected to grow as healthcare providers seek to address this pressing health crisis. Furthermore, advancements in stent technology, such as drug-eluting stents, enhance the effectiveness of these interventions, potentially leading to a higher adoption rate among healthcare professionals. This trend indicates a robust growth trajectory for the surgical stents market, as more patients require interventions to manage their cardiovascular health. ### Aging Population and Increased Healthcare Expenditure the demographic shift towards an aging population in the US significantly impacts the surgical stents market.. As individuals age, they are more susceptible to various health conditions, including those requiring stenting procedures. The US Census Bureau projects that by 2030, all baby boomers will be over 65 years old, leading to a higher prevalence of age-related diseases. Additionally, increased healthcare expenditure, driven by both public and private sectors, supports the adoption of advanced medical technologies, including surgical stents. In 2023, healthcare spending in the US reached approximately $4.3 trillion, with a substantial portion allocated to cardiovascular treatments. This financial commitment suggests a favorable environment for the surgical stents market, as healthcare providers invest in innovative solutions to meet the needs of an aging population. ### Rising Awareness and Education on Cardiovascular Health Growing awareness and education regarding cardiovascular health are pivotal in driving the surgical stents market. Public health campaigns and educational initiatives have significantly increased knowledge about the risks associated with cardiovascular diseases and the benefits of timely interventions. As patients become more informed, they are more likely to seek medical advice and treatment options, including stenting procedures. This trend is further supported by healthcare providers who emphasize preventive care and early intervention strategies. The American College of Cardiology reports that early detection and treatment can reduce the risk of severe complications, thereby increasing the demand for surgical stents. Consequently, this heightened awareness is likely to contribute positively to the growth of the surgical stents market. ### Supportive Reimbursement Policies and Insurance Coverage Supportive reimbursement policies and insurance coverage play a crucial role in the surgical stents market. The Centers for Medicare & Medicaid Services (CMS) and private insurers are increasingly recognizing the importance of stenting procedures in managing cardiovascular diseases. As a result, reimbursement rates for these interventions have improved, making them more accessible to patients. In 2023, approximately 80% of stenting procedures were covered by insurance, facilitating patient access to necessary treatments. This financial support encourages healthcare providers to offer stenting as a viable option for patients with arterial blockages. The favorable reimbursement landscape is likely to bolster the surgical stents market, as more patients can afford these life-saving interventions. ## Future Outlook The [Surgical Stents Market](https://www.marketresearchfuture.com/reports/surgical-stents-market-1044) is projected to grow at 4.83% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of cardiovascular diseases, and rising healthcare expenditure. **New opportunities:** - Development of biodegradable stents for enhanced patient outcomes. - Expansion of telehealth services for remote stent monitoring. - Investment in AI-driven analytics for personalized stent solutions. By 2035, the surgical stents market is expected to achieve substantial growth, driven by innovation and strategic investments. ## Segment Insights ### By Type: Coronary Stents (Largest) vs. Urological Stents (Fastest-Growing) In the US surgical stents market, coronary stents dominate the market share, significantly surpassing other segments due to their widespread application in treating coronary artery disease. Peripheral stents and biliary stents follow in terms of market presence, catering to specific vascular and biliary conditions. Urological and gastrointestinal stents, although showing growth, hold smaller shares in comparison. The overall competition in the segment is fierce, with leading players continuously innovating to enhance stent capabilities and patient outcomes. Growth trends in the surgical stents segment are propelled by an increase in cardiovascular diseases and advancements in stent technology, which improve safety and effectiveness. Specifically, urological stents are emerging rapidly due to increasing prevalence of urological disorders. Additionally, an aging population and rising awareness about minimally invasive procedures are influencing the demand across all stent types, shaping a robust market landscape. Coronary Stents (Dominant) vs. Urological Stents (Emerging) Coronary stents stand as the dominant force within the US surgical stents market, primarily utilized in the treatment of coronary artery disease. These stents are designed to provide structural support to narrowed arteries, facilitating increased blood flow. Their advanced design, often involving drug-eluting technologies, has made them a preferred choice among healthcare providers. In contrast, urological stents are classified as an emerging segment and are increasingly recognized for their role in managing urinary obstructions and related disorders. The rise in urological procedures and innovations in stent materials are enhancing their market appeal, positioning them for accelerated growth. ### By Material: Metal Stents (Largest) vs. Bioabsorbable Stents (Fastest-Growing) In the US surgical stents market, the material segment is primarily dominated by metal stents, which account for a substantial share due to their durability and strength. These stents are widely used in various surgical procedures, contributing to their dominance. Polymer and coated stents follow, capturing lesser shares but still playing critical roles in specific applications. Bioabsorbable stents, while currently smaller in market share, are gaining attention for their innovative properties, allowing for temporary support that dissolves over time. The growth trends in this segment are heavily influenced by advancements in materials technology and an increasing demand for minimally invasive procedures. Bioabsorbable stents are particularly appealing due to their potential to reduce long-term complications associated with permanent implants, positioning them as a key growth driver. The overall trend indicates a shift towards materials that enhance patient outcomes, prompting research and development in bioabsorbable options while maintaining the strong market presence of metal stents that continue to fulfill critical needs in surgical interventions. Metal Stents (Dominant) vs. Bioabsorbable Stents (Emerging) Metal stents are characterized by their robustness and reliability, making them the go-to choice for many surgical applications. Their ability to withstand high pressures and provide long-term support has established them as the dominant segment in the US surgical stents market. In contrast, bioabsorbable stents are emerging as a novel solution, designed to dissolve over time, thus eliminating the need for surgical removal. This innovative approach caters to a growing demand for temporary stenting solutions, particularly in cardiac procedures. As patients and healthcare providers seek alternatives that minimize long-term risks associated with permanent implants, bioabsorbable stents are gaining traction, attracting investment and fostering technological advancements that promise to enhance their performance in clinical settings. ### By End-user: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing) In the US surgical stents market, hospitals hold the largest market share due to their comprehensive surgical services and advanced infrastructural capabilities. The significant volume of procedures performed in hospitals, coupled with their ability to provide specialized care, solidifies their leading role in the market. Meanwhile, ambulatory surgical centers are emerging as a strong competitor, capturing an increasing share owing to their cost-effectiveness and convenience, appealing to both patients and healthcare providers. The growth trends for the end-user segment are largely driven by advancements in surgical procedures and an increasing focus on minimally invasive techniques. Moreover, the shift towards outpatient care is propelling ambulatory surgical centers to the forefront of the market. Specialty clinics, while growing, are trailing in overall market share as hospitals and ambulatory surgical centers rapidly evolve to meet patient needs, expanding their service offerings and enhancing patient accessibility. Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging) Hospitals are characterized by their extensive surgical facilities, high patient turnover, and specialized medical teams, making them the dominant force in the surgical stents market. The integration of advanced medical technologies and a wide range of services enables hospitals to cater to complex cases effectively. On the other hand, ambulatory surgical centers are gaining traction as an emerging choice for patients, providing quicker procedures and lower costs. These centers are particularly attractive for less complex surgeries, with a focus on improving patient experience and reducing recovery times. As healthcare systems evolve, both segments are likely to adapt and grow, although hospitals will continue to maintain a significant share due to their diverse offerings. ### By Delivery Method: Balloon-Expandable Stents (Largest) vs. Self-Expanding Stents (Fastest-Growing) In the US surgical stents market, Balloon-Expandable Stents hold the largest market share due to their prevalent use in a variety of procedures, ensuring effective angioplasty results. Self-Expanding Stents, although smaller in share, are gaining traction due to their unique advantages in specific applications, making them a notable player in the segment. The growth trends for these delivery methods are driven by advancements in stent technology and increasing demand for minimally invasive procedures. As healthcare providers continue to adopt innovative solutions, the popularity of Self-Expanding Stents is projected to rise significantly, reflecting a shift toward more adaptable and patient-friendly options in surgical procedures. Delivery Method: Balloon-Expandable Stents (Dominant) vs. Self-Expanding Stents (Emerging) Balloon-Expandable Stents are recognized for their reliability and effectiveness, particularly in treating coronary artery disease, as they can be expanded using a balloon catheter. This segment's stronghold is attributed to its proven performance and wide acceptance among clinicians. Conversely, Self-Expanding Stents, which utilize unique materials that allow them to expand automatically upon placement, are rapidly emerging due to their effectiveness in situations where vessel anatomy is challenging. Their adaptability in different vascular environments is enhancing their market presence, appealing to a growing number of healthcare professionals seeking innovative approaches in stenting techniques. ## Competitive Benchmarking The surgical stents market is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for minimally invasive procedures. Key players such as Medtronic (IE), Boston Scientific (US), and Abbott Laboratories (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Medtronic (IE) focuses on innovation, particularly in drug-eluting stents, while Boston Scientific (US) emphasizes strategic partnerships to expand its product portfolio. Abbott Laboratories (US) is investing heavily in research and development to introduce next-generation stent technologies, which collectively shape a competitive environment that is increasingly reliant on technological differentiation and strategic collaborations.In terms of business tactics, companies are localizing manufacturing to reduce costs and optimize supply chains, which is crucial in a moderately fragmented market. The competitive structure is influenced by the collective actions of these key players, who are not only vying for market share but also striving to enhance operational efficiencies. This competitive interplay fosters an environment where innovation and strategic positioning are paramount, as companies seek to differentiate themselves in a crowded marketplace. In October Medtronic (IE) announced the launch of a new line of bioresorbable stents, which are designed to dissolve over time, reducing the need for long-term implantation. This strategic move is significant as it aligns with the growing trend towards less invasive solutions and could potentially capture a larger share of the market focused on patient-centric care. The introduction of such innovative products may enhance Medtronic's competitive edge and appeal to healthcare providers seeking advanced treatment options. In September Boston Scientific (US) entered into a partnership with a leading technology firm to integrate AI into its stent design process. This collaboration aims to leverage artificial intelligence to optimize stent performance and patient outcomes. The strategic importance of this partnership lies in its potential to revolutionize product development, allowing for more personalized and effective stent solutions, thereby enhancing Boston Scientific's market position. In August Abbott Laboratories (US) completed the acquisition of a smaller biotech firm specializing in advanced stent coatings. This acquisition is pivotal as it not only expands Abbott's technological capabilities but also strengthens its product offerings in the competitive landscape. By integrating these advanced coatings, Abbott aims to improve the efficacy and safety of its stents, which could lead to increased market share and customer loyalty. As of November current trends in the surgical stents market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the need to collaborate to stay competitive. Looking ahead, the competitive differentiation in this market is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift underscores the importance of not only developing cutting-edge products but also ensuring that they are delivered efficiently and sustainably. ## Recent News & Developments Recent developments in the US Surgical Stents Market have shown significant activity, with companies like Boston Scientific and Medtronic launching new devices aimed at improving patient outcomes. Notably, Abbott has been focusing on innovations that cater to the cardiovascular sector, enhancing its presence in the market. In terms of mergers and acquisitions, Halyard Health recently announced strategic collaborations to enhance its product offerings, while Teleflex has made moves to acquire specific technologies that bolster its minimally invasive solutions. Furthermore, in June 2022, Stryker completed its acquisition of Mako Surgical, expanding its capabilities in robotic-assisted surgery, which indirectly impacts the stent market. The US Surgical Stents Market valuation is witnessing growth driven by rising cardiovascular diseases and increased demand for minimally invasive procedures, with organizations advocating for better healthcare measures. Major companies including Johnson and Johnson, AngioDynamics, and Cook Medical are responding to these trends by investing in Research and Development to introduce advanced stent technologies. Market dynamics in the past couple of years, particularly in 2020 and 2021, have intensified competition, as firms strive to maintain leadership amidst evolving healthcare needs and technological advancements. ## Report Scope | MARKET SIZE 2024 | 1274.7(USD Million) | | --- | --- | | MARKET SIZE 2025 | 1336.27(USD Million) | | MARKET SIZE 2035 | 2141.58(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.83% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (IE), Boston Scientific (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Johnson & Johnson (US), Terumo Corporation (JP), Cook Medical (US), Cardinal Health (US), Stryker Corporation (US) | | Segments Covered | Type, Material, End-user, Delivery Method | | Key Market Opportunities | Advancements in biodegradable materials enhance patient outcomes in the surgical stents market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the surgical stents market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the market valuation of the US surgical stents market in 2024?** A: The market valuation of the US surgical stents market was $1274.7 Million in 2024. **Q: What is the projected market valuation for the US surgical stents market by 2035?** A: The projected market valuation for the US surgical stents market is $2141.58 Million by 2035. **Q: What is the expected CAGR for the US surgical stents market during the forecast period 2025 - 2035?** A: The expected CAGR for the US surgical stents market during the forecast period 2025 - 2035 is 4.83%. **Q: Which segment had the highest valuation in the US surgical stents market in 2024?** A: In 2024, the segment with the highest valuation was Coronary Stents, valued between $500.0 Million and $850.0 Million. **Q: What are the key players in the US surgical stents market?** A: Key players in the US surgical stents market include Medtronic, Boston Scientific, Abbott Laboratories, and Johnson & Johnson. **Q: What is the valuation range for Peripheral Stents in 2024?** A: The valuation range for Peripheral Stents in 2024 was between $300.0 Million and $500.0 Million. **Q: Which delivery method segment is projected to grow significantly by 2035?** A: The Self-Expanding Stents segment is projected to grow significantly, with a valuation range of $774.7 Million to $1291.58 Million by 2035. **Q: What is the valuation range for Bioabsorbable Stents in 2024?** A: The valuation range for Bioabsorbable Stents in 2024 was between $200.0 Million and $350.0 Million. **Q: How do the valuations of hospitals compare to specialty clinics in the US surgical stents market?** A: In 2024, hospitals had a valuation range of $500.0 Million to $850.0 Million, while specialty clinics ranged from $424.7 Million to $691.58 Million. **Q: What is the projected valuation for Coated Stents by 2035?** A: The projected valuation for Coated Stents by 2035 is between $274.7 Million and $441.58 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-surgical-stents-market-20049*